Our patients progressed rapidly once the tumor primarily had INI-1 deficiency, and the second patient which showed some INI-1 loss at diagnosis by IHC had a more rapid clinical progression, and this focal losses of nuclear INI-1 expression in an ET may be a clue to the diagnosis and nature of these neoplasms. This evidence concerns the gene SMARCB1 and neoplasm.